Form D — Trails Edge Biotechnology USA Fund, LP
0001493152-26-030078 · filed Jun 25, 2026
Offering
- Industry
- Pooled Investment Fund
- Exemptions
- 3C, 3C.7
- Total offering
- —
- Total sold
- $205,966,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Trails Edge Biotechnology USA Fund, LP
- CIK
- 2070467
- Entity
- Limited Partnership
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 3445 PEACHTREE ROAD NE
ATLANTA, GA 30326 - Phone
- 770-600-9010
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
- Trails Edge Biotechnology Fund GP, LP · Executive OfficerAtlanta, GA Find on LinkedIn ↗
-
- Trails Edge Capital Partners, LP · Executive OfficerAtlanta, GA Find on LinkedIn ↗
-
Ortav Yehudai · Executive OfficerAtlanta, GA Find on LinkedIn ↗
-
Matthew Diaz · Executive OfficerAtlanta, GA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗